DermaBio

DermaBio delivers AI-based precision medicine via skin biomarkers and predictive modeling.

Health Tech & Life Sciences
Active
Pre-Seed Jerusalem, Israel Founded 2022
Last updated 2026-06-18
Total raised
Last: 2025-04
Stage
Pre-Seed
Founded
2022
Headcount
6
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

The Future of Precision Medicine Starts with Your Skin

Today, prescribing biologic drugs is a costly guessing game — one that’s growing rapidly as biologics are set to become the standard of care across many diseases. Trial and error treatment leads to wasted time, poor outcomes, and skyrocketing healthcare costs. DermaBio is changing this.

Our AI-powered precision medicine platform combines skin biomarker analysis, a proprietary clinical assay, and advanced data modeling to predict response to biologic therapies. This empowers smarter, faster, and more cost-effective care across multiple diseases.

Our data driven platform combines clinical assays and advanced data modeling to predict response from skin biomarker analysis. Our non-invasive skin swab integrates seamlessly into clinical workflows—fast, painless, and patient-friendly. Clinicians and payers get actionable data.

In short: One versatile platform. A win for clinicians, patients and payers.

Funding history · 2 rounds · — total

2025-04
Undisclosed
2022-11
Undisclosed

Q&A

What is DermaBio's primary focus?
DermaBio delivers AI-based precision medicine via skin biomarkers and predictive modeling to predict response to biologic therapies.
When was DermaBio founded?
DermaBio was founded in July 2022.
Which investors participated in DermaBio's November 2022 funding round?
MindUP participated in DermaBio's funding round in November 2022.
What is DermaBio's current funding stage?
DermaBio is currently in the Pre-Seed stage.
Who are the co-founders of DermaBio?
Miriam Oron Ph.D. is the Co-founder & CEO, and Meital Portugal is the Co-founder & CTO of DermaBio.
In which countries does DermaBio have offices?
DermaBio has offices in Israel (Jerusalem) and the United States (Pittsburgh).
What technologies does DermaBio utilize?
DermaBio utilizes Artificial Intelligence, Machine Learning, Platforms & Interfaces, and Software.

Team · 2

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & CTO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Artificial IntelligenceMachine LearningPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesProvidersInsurance Companies
Business model
B2B

Highlights

1 PatentsVerified

Tags

biomarkersprecision-medicinenon-invasivedigital-healthcaremachine-learningdermatologyskinautoimmune-diseasesdecision-support
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitedermab.io
LinkedInlinkedin.com/company/86826650

Identifiers & details

Founded2022-7
Employees (exact)6
OfficesPittsburgh

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domaindermab.io